NatWest Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

NatWest Group’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-74,426	Closed	-$1.22M	–	367
2015 Q3	$1.22M	Buy	74,426 +21,035	+39%	+$431K	0.03%	179
2015 Q2	$1.22M	Sell	53,391 -21,035	-28%	-$419K	0.02%	180
2015 Q1	$1.13M	Sell	74,426 -17,444	-19%	-$227K	0.01%	208
2014 Q4	$1.11K	Buy	91,870 +2,704	+3%	+$30.9K	0.01%	209
2014 Q3	$1.01K	Buy	89,166 +19,079	+27%	+$218K	0.01%	260
2014 Q2	$847K	Buy	70,087 +14,021	+25%	+$166K	0.04%	284
2014 Q1	$653K	Sell	56,066 -404	-0.7%	-$6.84K	0.03%	300
2013 Q4	$998K	Buy	56,470 +11,973	+27%	+$201K	0.03%	436
2013 Q3	$640K	Sell	44,497 -11	-0%	-$168	0.02%	608
2013 Q2	$670K	Buy	+44,508	New	+$587K	0.01%	547

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

NatWest Group's MNTA Position: Q4 2015 in Review

NatWest Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2015, closing a stake of 74,426 shares — an estimated $1.22M sold.

NatWest Group first reported a position in MNTA in Q2 2013 and held it in 10 quarters. The position peaked at $1.22M in Q3 2015. 164 funds tracked by Wall St. Rank hold MNTA as of Q4 2015.

NatWest Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
NatWest Group sold 74,426 Momenta Pharmaceuticals, Inc. shares in Q4 2015, an estimated $1.22M.
NatWest Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
NatWest Group's Momenta Pharmaceuticals, Inc. position peaked at $1.22M in Q3 2015.
164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.